Certara (CERT) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
15 May, 2026Opening remarks and agenda
Meeting called to order virtually, with shareholders able to submit questions online.
Directors and executive officers introduced, with special recognition for outgoing board members.
Meeting conducted in accordance with bylaws and proper notice provided to all shareholders.
Board and executive committee updates
Three directors, Arjun Bedi, Stephen McLean, and Jon Resnick, stood for re-election as Class III directors.
Cynthia Collins and Rose Crane recognized for their service as their board terms concluded.
Shareholder proposals
Three proposals presented: election of directors, ratification of RSM as auditor, and advisory vote on executive compensation.
Board recommended voting in favor of all proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Certara
- FY 2025 revenue rose 9% to $418.8M, but 2026 outlook is flat as AI and operational changes continue.CERT
Q4 20259 Jul 2026 - Q1 2025 revenue up 10%, bookings up 12%, profitability returns, and $100M buyback announced.CERT
Q1 20258 Jul 2026 - Q1 revenue up 1% to $106.9M; net loss $8.8M; divestiture and AI initiatives advanced.CERT
Q1 20268 Jul 2026 - Strategic realignment and AI integration drive growth and innovation across clinical development.CERT
Jefferies Global Healthcare Conference 20263 Jun 2026 - AI-driven innovation, regulatory support, and market momentum set the stage for double-digit growth.CERT
RBC Capital Markets Global Healthcare Conference 202619 May 2026 - Director elections, auditor ratification, and executive pay are key 2026 meeting topics.CERT
Proxy filing3 Apr 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.CERT
Proxy filing3 Apr 2026 - AI-driven product launches and disciplined cost control set the stage for cautious 2026 growth.CERT
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - 2026 guidance reflects stable markets, strong biosimulation growth, and operational transformation.CERT
Leerink Global Healthcare Conference 20269 Mar 2026